Circulation, Vol 85, 2100-2109, Copyright © 1992 by American Heart Association
KB Davis, EL Alderman, AS Kosinski, E Passamani and JW Kennedy
BACKGROUND. The Coronary Artery Surgery Study (CASS) Registry is used to
evaluate the effect of various baseline clinical and angiographic factors
on mortality after acute out-of-hospital myocardial infarction (MI) in
patients with and without prior coronary bypass surgery. METHODS AND
RESULTS. Among the CASS Registry patients, there were 985 medical and 369
surgical patients who had an MI out of the hospital within 3 years after
enrollment. In the medical group, 20% died before hospitalization. Medical
patients with baseline three-vessel disease or left ventricular (LV)
dysfunction were at high risk of immediate death. For medical patients who
were hospitalized with MI, mortality was higher for older patients and
those with severe angina as well as for those with extensive disease and LV
dysfunction. The total 30-day mortality for medical patients was 36%. In
the surgical group, 12% died before hospitalization. Surgical patients with
LV dysfunction or prior MI were at highest risk of immediate death. For
surgical patients hospitalized with MI, mortality was significantly
increased only for patients with baseline LV dysfunction. Mortality was not
significantly higher for surgical patients with multivessel disease. The
total 30-day mortality for surgical patients was 21%. The prior use of
aspirin or beta-blockers was not associated with reduced mortality from
subsequent MI for either medical or surgical patients. Although the
prevalence of cigarette smoking was high among patients who had an MI,
cigarette smoking did not alter the infarct-related mortality rate.
CONCLUSIONS. The surgical group had lower mortality rates than the medical
group both immediately (p = 0.001), after hospitalization (p less than
0.0001), and at 30 days (p less than 0.0001).
ARTICLES
Early mortality of acute myocardial infarction in patients with and without prior coronary revascularization surgery. A Coronary Artery Surgery Study Registry Study
University of Washington, Seattle.
This article has been cited by other articles:
![]() |
K.-H. Mak and D. P. Faxon Clinical studies on coronary revascularization in patients with type 2 diabetes Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Detre, M. S. Lombardero, M. M. Brooks, R. M. Hardison, R. Holubkov, G. Sopko, R. L. Frye, B. R. Chaitman, and The Bypass Angioplasty Revascularization Investiga The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction N. Engl. J. Med., April 6, 2000; 342(14): 989 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stone, B. R. Brodie, J. J. Griffin, L. Grines, J. Boura, W. W. O'Neill, C. L. Grines, and for the Second Primary Angioplasty in Myocardial I Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., March 1, 2000; 35(3): 605 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Forrester and P. K. Shah Lipid Lowering Versus Revascularization : An Idea Whose Time (For Testing) Has Come* Circulation, August 19, 1997; 96(4): 1360 - 1362. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |